LAST ONE 7. At present, stem cell-based therapies are the clinical standard of care for 1 point only a few conditions, including leukemia and macular degeneration.
Before stem cell therapies can be ethically approved for other conditions,
which safety assessments should be confirmed? Select all the answers that
apply. *
Stem cells should not have harmful mutations
Stem cells should not spread beyond the site of the transplant
Ste cell treatment should not cause tumors
Stem cell treatment should not overrun costs